Skip to main content
Download PDF

Sex-based influential factors for dental caries in patients with schizophrenia

BMC Psychiatry volume 23, Article number: 735 (2023) Cite this article

Abstract

Background

Schizophrenia is a common mental disorder that seriously affects patients’ daily lives and brings heavy psychological and economic burdens to their families and society. The oral problems of patients with schizophrenia are gradually gaining attention, among which dental caries are among the most common oral diseases. Sex differences may be related not only to the various clinical symptoms of schizophrenia but also to different oral hygiene statuses; therefore, the main purpose of this paper is to investigate sex differences related to influencing factors for dental caries in patients with schizophrenia.

Method

Inpatients with schizophrenia over 18 years old were included in this study, and multidimensional indicators such as demographics, symptom and cognitive impairment assessments, medications, and the caries index of decayed, missing, and filled teeth (DMFT) were collected. An analysis of sex-based influential factors for dental caries in schizophrenia patients was performed.

Results

Four-hundred and ninety-six patients with schizophrenia were included, with a mean age of 46.73 ± 12.23 years, of which 142 were females and 354 were males. The mean DMFT was significantly higher in males (8.81 ± 8.50) than in females (5.63 ± 6.61, p < 0.001), and the odd ratio of caries in males to females was significantly higher as well (OR = 2.305, p < 0.001). The influential factors of caries in male patients were independently associated with age and smoking status, in which current smokers were at the highest risk for developing caries, and different smoking statuses had various influencing factors for caries. The influencing factors for caries in female patients were independently associated with age, antipsychotic dose, PANSS-positive symptoms, and MMSE levels.

Conclusion

Our findings suggest sex differences exist among influential factors for caries in patients with schizophrenia. These risk factors may even be associated with and affect the treatment and prognosis of psychiatric symptoms in patients. Therefore, oral hygiene management of patients with schizophrenia should be enhanced. These differential factors provide new visions and ideas for formulating individual interventions, treatments, and care priorities.

Peer Review reports

Introduction

Schizophrenia is a common serious psychiatric disorder characterized by positive symptoms, negative symptoms, and cognitive deficits [1] and imposes a heavy psychological and economic burden on families, households, and society [2, 3]. Sex differences in symptoms, cognition, medication preferences, and prognosis are currently present in patients with schizophrenia. For example, men have stronger objective social cognition correlated with nonsocial functioning [4] and visual working memory function [5] than women. Meanwhile, women have verbal fluency associated with hostile bias [6] and perform better than men in processing speed, switching, and verbal situational memory [5]. Sex-based differences in subjective tolerance of antipsychotic medications [7] lead to better medication efficacy and prognosis in women than men [8], but women are more likely to gain weight [9]. These differences may be related to the differences in brain structure and brain function [10], gene expression [11], or the microbiota-brain-gut axis [12].

Dental caries is the most common oral disease. Caries can affect the chewing function of patients and the growth and development of affected children [13] and is the leading cause of tooth loss, with an increasing trend in the rate of untreated dental caries [14, 15]. Some studies have found that dental caries can reflect the change in the inorganic level of the human body [16], the degree of socioeconomic stress [17], and the degree of depression and anxiety of patients [18]. The development of dental caries is often associated with smoking, genetics, dietary preferences, inadequate salivary secretion, poorly controlled diabetes [19], or oral flora disorders [20]. Studies have shown that the dominant oral microbial flora causing caries differs from periodontal and gingival diseases [21]. There are controversies regarding sex differences in caries occurrence. Large-scale epidemiological surveys in South Asia [22], China [23, 24], Portugal [25], or Russia [26] have shown that women are more likely to develop caries, which may be explained by a higher intake of snacks than men [27], hormonal fluctuations due to pregnancy or menstruation [27], or a greater abundance of acid-producing cariogenic lactococci [28]. However, among hospitalized patients with severe schizophrenia, male elderly patients have poorer oral hygiene than females, including a higher caries index and risk [29, 30].

There is still a lack of comprehensive studies on sex differences in caries and related multidimensional factors in patients with schizophrenia. Therefore, this paper intends to investigate the influential factors for sex-based differences in caries in patients with schizophrenia, to find the clinical representation and theoretical basis of oral microbial community differences, and to help develop a comprehensive strategy for sex-based differential oral management in patients with schizophrenia.

Methods

The Beijing Huilongguan Hospital Ethics Committee approved the study, and all patients or their legal guardians provided written informed consent. The protocol involving human participants and human data has been performed in accordance with the Declaration of Helsinki. This reporting was performed per the Strengthening the Reporting of Observational studies in Epidemiology (STROBE) guidance [31].

Patients

Patients with schizophrenia who met the inclusion criteria from four psychiatric hospitals were included in this study. We collected patient demographics (age, sex, BMI), substance dependence status (smoking, drinking), comorbidities (diabetes, hypertension, suicide status, insomnia status), psychiatric history, medications (type of medication, dose), Positive And Negative Syndrome Scale (PANSS) [32], Mini-Mental State Examination (MMSE), Global Deterioration Scale (GDS) [33], Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) [34] and oral health status.

Inclusion criteria: 1, Han Chinese inpatients aged 18 years and over; 2, patients with schizophrenia diagnosed by the Structured Clinical Interview for the DSM-IV (SCID) criteria. Exclusion criteria: 1, patients with epilepsy, cranial injury, periodic paralysis, or other neurological disorders; 2, patients with cardiovascular disease, other metabolic disorders, or endocrine disorders; 3, patients with substance dependence (not tobacco or alcohol dependence); 4, patients who were unable to cooperate with the completion of oral and all other tests; 5, patients with incomplete data.

Caries diagnosis

The DMFT (decayed, missing, and filled teeth) is a commonly used caries assessment index that reflects oral hygiene status [35]. According to the World Health Organization’s oral hygiene standards [36], caries is defined as “a lesion in a pit or fissure, or on a smooth tooth surface, [that] has an unmistakable cavity, undermined enamel, or a detectably softened floor or wall.” The decayed tooth (DT), missing tooth (MT), and filled tooth (FT) counts of the patients were measured with an orofacial microscope and probe, and the cases of tooth loss and filling due to non-carious (traumatic) factors were excluded. The number of 28 permanent teeth was used as the reference for the number of teeth in a healthy Chinese adult [37]. DMFT > 0 was used as the grouping condition for caries and non-caries. Dentists were trained uniformly before the assessment and passed the kappa concordance test (κ = 0.90).

Statistical analysis

Statistical analysis was performed using SPSS 26 (IBM Corporation, New Orchard Road, Armonk, NY 10,504, USA). Categorical variables were analyzed by the chi-square test. Continuous variables were first tested for normality by the Kolmogorov-Smirnov test and then for homogeneity of variance by the Levene test. The Mann-Whitney U-test analyzed non-normality or variance-inequality variables. Normal variables were tested by t-test. With covariates including age, BMI, smoking, and illness duration, a two-way analysis of covariance (ANCOVA) was used for sex differences in clinical symptoms and medication with independent predictors being sex (male vs. female) and diagnosis (caries vs. non-caries). Correlation analysis was performed using the Spearman test, binary logistic regression was used for independent factor analysis of caries, and the Bonferroni Test was used for multiple comparison correction (α = 0.05/35 ≈ 0.0014). Continuous variables were shown as mean ± standard deviation (\(\stackrel{\text{-}}{\text{x}}\pm\text{ std.}\)). A p ≤ 0.05 was considered with a statistical significance.

Results

Participant demographics

After excluding those who did not meet the inclusion criteria from 988 investigated patients, 496 patients were included for the analysis, with a mean age of 46.73 ± 12.23 years and a mean duration of illness of 21.42 ± 11.81 years, of whom 142 were women and 354 were men. Table 1 shows the significant differences between men and women in terms of DMFT, DT, caries status, BMI, marriage, education levels, smoking, drinking, diabetes, family history, age at first hospitalization, types and numbers of antipsychotic medications, and GDS ranks (all p < 0.05). Only DMFT, DT, caries status, marital status, smoking, drinking, and family history passed the Bonferroni test (α ≈ 0.0014). Oral problems, including DMFT, DT, and caries risk (odd ratio, OR = 2.305), were more significantly severe in men than in women (all p < 0.05). Table 2 shows an interaction effect on age, education, and age at first hospitalization between caries and sex. Only the interaction effect of age with sex (p < 0.001) was Bonferroni corrected (α = 0.0014).

Table 1 Characters between female and male patients with schizophrenia
Full size table
Table 2 Demographic and clinical characteristics between with and without caries grouped by sex in patients with schizophrenia
Full size table

Analysis of risk factors for dental caries in male patients

Table 2 shows statistical significance in age (p < 0.001), smoking (p < 0.001), hypertension (p = 0.007), diabetes (p = 0.007), type of antipsychotic drugs (p = 0.007), MMSE level (p = 0.004), GDS ranks (p = 0.040), attention subscale score (p = 0.011), and delayed memory subscale score (p = 0.012) among men between caries groups. Only the comparison of age and smoking passed the Bonferroni test. Supplementary Table 1 shows caries were correlated with age, type of antipsychotic drugs, diabetes, hypertension, smoking status, MMSE levels, GDS ranks, attention scale score, and delayed memory scale score (all p < 0.05), with age, smoking, and illness duration passing the Bonferroni test. Multivariate analysis shows that the independent risk factors for caries are age (p < 0.001, OR = 1.116, 95%CI = 1.074–1.159) and current smoking (p = 0.001, OR = 5.949, 95%CI = 2.049–17.278), adjusted R2 = 0.356, as shown in Table 3. In the smoking group, the OR for dental caries was 1.308 (χ2 = 0.470, p = 0.493) between previous and non-smoking patients and 5.696 (χ2 = 11.610, p = 0.001) between current and previous smoking patients.

Table 3 The risk-factor analysis of caries in patients with schizophrenia
Full size table

Analysis of risk factors for dental caries in female patients

Table 2 shows significant differences in age (p < 0.001), education level (p < 0.001), diabetes (p = 0.036), first-episode onset age (p = 0.031), age at first hospitalization (p = 0.018), the dose of antipsychotic drugs (p = 0.007), insomnia scores (p = 0.007), and PANSS positive scale scores (p = 0.047) among female patients between caries groups. Only age and education level passed the Bonferroni test. Caries were correlated with age, diabetes, age at first-episode onset, age at first hospitalization, insomnia score, the dose of antipsychotic drug, and PANSS positive score (all p < 0.05), as shown in Supplementary Table 1. Multiple regression analysis showed that age, the dose of antipsychotic medications, PANSS positive scores, MMSE level (mild), and language subscale scores were independent risk factors (adjusted R2 = 0.587), as shown in Table 3.

Discussion

Some studies have reported that people with severe mental illness have significantly higher numbers of decayed, missing, or filled teeth than the general population [38]. This study shows similarities and differences in sex-related influential factors for caries between male and female patients with schizophrenia, consistent with our previous research findings [29]. Among them, males are more prone to suffer caries or tooth loss than females, with a higher risk of caries than females. Age is a common risk factor for dental caries in males and females with schizophrenia, which is consistent with the results of Velasco-Ortega et al. [39] and Yang et al. [29]. Caries is correlated with smoking in males with different risk factors for different smoking statuses, while in females, caries is correlated with the dose of antipsychotic medication, PANSS Positive subscale scores, dementia severity (MMSE), or language function subscale scores. The following is an analysis of the relevant factors of dental caries in men and women.

Common risk characteristics for male and female caries

This study proves that age-induced oral aging is an undeniable natural process [40]. The age-related changes in oral anatomy and function mainly manifest as enamel wear, fragmentation [41], fracture lines, color deposition, and atrophy of pulp chambers and dentinal tubules [42]. At the same time, aging may promote changes in the oral microbial ecology. Previous studies have shown that the diversity of oral bacterial microbiota in healthy Chinese adults is related to sex and age [43]. Further, the abundance and types of oral microbiota in the elderly population may differ from those in young people [44]; for example, there is excessive growth of anaerobic bacteria in the elderly [45, 46]. Changes in the oral flora may trigger inflammatory reactions in the soft and hard tissues of the tooth body [47]. Animal experiments have also confirmed that aging may damage the tooth body and periodontal environment by promoting chronic inflammation, such as interleukin-6 (IL-6) and IL-17, and reducing the ability of dental pulp regeneration [48]. These factors all promote the occurrence of caries with increasing age. In addition, aging cells accumulate in the alveolar bone and promote aging-related secretory phenotypes. At the same time, they have synergistic effects with oral bacteria, destroying hard tooth tissue, causing severe loss of alveolar bone, and aggravation of periodontal inflammation [49]. Oral infectious pathogens, such as cariogenic bacteria, may even cause stroke, diabetes, lower respiratory tract infection, premature delivery, and pneumonia [50, 51], so it is imperative to control oral caries in elderly hospitalized schizophrenic patients.

Analysis of risk factors for caries due to sex difference

Analysis of risk factors of caries in male patients with schizophrenia

This study showed a smoking rate of 59.7% in male patients with schizophrenia, consistent with the rate of 57.5% observed in previous Chinese studies [52]. The high smoking rate in male patients with schizophrenia may be due to several reasons. First, the ward’s social culture, the hospital’s acquiescence, and the difficulty quitting smoking are important factors [53]. Second, nicotine acts on nicotinic acetylcholine receptors by improving neurochemical deficits and thus may help alleviate some symptoms of schizophrenia [54]. Third, there are multiple co-morbid genes between smoking and schizophrenia, and smoking may drive some risk genes for schizophrenia [55]. For example, CHRNA2 is a co-acting target of smoking behavior and schizophrenia [55]. Further, CHRNA5 with variants on chromosome 15q25 was also found to change the daily smoking amount [56]. Smoking alters the composition and diversity of oral microorganisms, increasing cariogenic bacteria, e.g., Streptococcus mutants and Lactobacilli fermentum [57]. Smoking can also change the abundance of salivary microbes [58] and the associated metabolic functions of the microbial communities [59], leading to a greater susceptibility to dental caries [60]. In addition, poor compliance of psychiatric patients makes caries treatment more difficult.

This study showed no statistically significant difference in caries risk between patients who used to smoke and those who never smoked. In contrast, the OR was 5.7 in current-smoking patients compared to those who used to smoke. Though Velasco-Ortega et al. [39] and Yang et al. [29] both reported that smoking is a risk factor for patients with schizophrenia, they did not further investigate the difference between sex, but our results made up for this deficiency. Our results indicate that smoking cessation reduces the risk of caries and is consistent with previous studies that found that smoking cessation reduces the risk of periodontitis [61] and the rate of tooth loss [62]. After smoking cessation, the altered oral microbial community may explain this, such as the reduced abundance of Porphyromonas gingivalis, Dialister pneumosintes, and Treponema denticola, or the recolonization of beneficial bacteria [63].

Analysis of risk factors of caries in female patients with schizophrenia

The results of this study suggest that cognitive impairment (MMSE) in female patients is associated with an increased risk of caries, which is consistent with previous findings [64]. For instance, a correlation was found between patients’ cognitive abilities and dental caries in a study of young and middle-aged adults [65]. Although relatively few studies specifically explored the degree of MMSE and oral hygiene in schizophrenia patients, such studies in elderly Alzheimer’s patients are more comprehensive and in-depth. For example, it has been found that reduced cognitive function in patients may be associated with oral problems such as periodontitis, gingivitis, alveolar bone loss, or attachment loss [66]. Inflammatory factors, such as IL-1β and tumor necrosis factor-alpha (TNF-α), are the first to be upregulated when periodontal inflammation occurs, and they may promote a pro-inflammatory environment in the brain that leads to the development of cognitive dysfunction [67]. Experiments in mice have found that saliva-associated oral microorganisms can exacerbate dementia symptoms through the gut-brain axis [68]. In addition, Porphyromonas gingivalis actively invaded the brains of mice during infection [69], leading to beta-amyloid deposition and causing cognitive impairment [67]. This point may be an initiating factor for the reduced delayed verbal recall function in dementia patients [70]. Clinical postmortem reports confirmed the presence of Porphyromonas gingivalis in the brain of Alzheimer’s patients [71], suggesting that oral microorganisms may have the ability to influence cognition in patients with dementia. The presence of oral microorganisms represented by Porphyromonas gingivalis may be associated with cognitive impairment, which may also explain the finding of cognitive alteration in patients with caries in our study. In other words, the disturbed oral ecology of patients with schizophrenia may further contribute to their cognitive impairment and the increased risk of developing dental caries.

Previous studies have shown an independent correlation between PANSS-positive symptoms and the number of lost teeth [72], and positive symptoms also increase the risk of caries [73]. These conclusions may suggest that the increase in positive symptoms will increase caries risk in female patients in this study. Positive symptoms, including hallucinations and delusions, as the main symptoms of schizophrenia, may have different effects on the onset and development of dental caries, so in-depth research is needed.

The results of this study indicate that an increase in the dosage of antipsychotic drugs in female patients with schizophrenia leads to an increased risk of dental caries since most antipsychotic drugs are bacterial antagonists [74], which may lead to a disruption of the patient’s oral or gut microbiota, particularly in women [75]. Long-term and high-dose use of antipsychotic medication in patients with schizophrenia may lead to the emergence of cariogenic bacterial resistance, such as a noticeable increase in gut lactobacilli levels after 24 weeks of risperidone treatment in first-episode schizophrenia patients [76]. Antipsychotic drugs can increase prolactin levels, and the degradation of prolactin inducible protein is correlated with caries [77]. In addition, antipsychotic drugs may reduce the number of white blood cells [78], disrupt the endocrine system [79], and lead to vitamin deficiency, reducing the immune response of the oral cavity and leaving the body susceptible to pathogenic microorganisms. At the same time, antipsychotic drugs can cause dry mouth [80, 81] and affect the oral mucosal barrier effect. Long-term use of high-dose antipsychotic drugs may exacerbate the adverse reactions mentioned above [82], leading to an increased risk of caries in patients.

Above all, these differences in patients with schizophrenia make it necessary to incorporate oral hygiene monitoring into routine management to improve the treatment approach and outcomes for patients with schizophrenia. Oral hygiene in patients with schizophrenia and the corresponding microbial-gut-brain axis-related mechanisms have become a hot topic, and studies on caries-based microbial oral hygiene problems may improve clinical symptom treatment and prognosis in patients with schizophrenia. Therefore, this study of sex differences in caries in patients with schizophrenia provides evidence for the individualized treatment of the disease.

Limitations

There were several limitations which should be concerned. Firstly, our study included hospitalized patients with a long course of illness and long-term use of antipsychotic drugs. The results of this study cannot be generalized to other types of patients, such as outpatient and community patients. Secondly, due to the different mechanisms of action, the oral effects of antipsychotic drugs may vary. Thirdly, the sample balance between sex is insufficient, and the sample size of included patients needs to be expanded. Fourthly, the data about antiparkinsonian agents had not been collected, since they may also affect caries development due to dry mouth. Finally, due to the cross-sectional nature of this survey, we cannot determine whether a causal relationship exists between clinical factors and dental caries. Further prospective research is needed to analyze the pathogenic factors of dental caries.

Conclusions

The risk of dental caries and caries index in males was higher than in females among hospitalized patients with schizophrenia, indicating that the oral hygiene status of male schizophrenia patients may be worse. This report has shown that age is a common risk factor for male and female caries. The risk of dental caries in male patients with schizophrenia is associated with smoking, general symptoms, BMI, and types of antipsychotic drugs. In contrast, in females, it is correlated to the dosage of antipsychotic medications used, positive symptoms, and degree of dementia. Therefore, to address the different caries risk factors brought about by sex differences, further prevention and treatment plans should be formulated. By regulating the oral microbiota and leveraging the new mechanism of the “brain-gut axis” pathway, new ideas and methods for diagnosing and treating schizophrenia can be developed.

Data Availability

The datasets generated and/or analyzed during the current study are not publicly available due but are available from the corresponding author on reasonable request.

References

  1. Zhu MH, Liu ZJ, Hu QY, Yang JY, Jin Y, Zhu N, Huang Y, Shi DH, Liu MJ, Tan HY, et al. Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial. Mil Med Res. 2022;9(1):59.

    PubMed  PubMed Central  CAS  Google Scholar 

  2. Peng MM, Xing J, Tang X, Wu Q, Wei D, Ran MS. Disease-Related risk factors for Caregiver Burden among Family Caregivers of persons with Schizophrenia: a systematic review and Meta-analysis. Int J Environ Res Public Health. 2022;19(3):1862.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Weber S, Scott JG, Chatterton ML. Healthcare costs and resource use associated with negative symptoms of schizophrenia: a systematic literature review. Schizophr Res. 2022;241:251–9.

    Article  PubMed  Google Scholar 

  4. Ferrer-Quintero M, Green MF, Horan WP, Penn DL, Kern RS, Lee J. The effect of sex on social cognition and functioning in schizophrenia. NPJ Schizophr. 2021;7(1):57.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Torniainen M, Suvisaari J, Partonen T, Castaneda AE, Kuha A, Perala J, Saarni S, Lonnqvist J, Tuulio-Henriksson A. Sex differences in cognition among persons with schizophrenia and healthy first-degree relatives. Psychiatry Res. 2011;188(1):7–12.

    Article  PubMed  Google Scholar 

  6. Kubota R, Okubo R, Ikezawa S, Matsui M, Adachi L, Wada A, Fujimaki C, Yamada Y, Saeki K, Sumiyoshi C, et al. Sex differences in Social Cognition and Association of Social Cognition and Neurocognition in Early Course Schizophrenia. Front Psychol. 2022;13:867468.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Barbui C, Nose M, Bindman J, Schene A, Becker T, Mazzi MA, Kikkert M, Camara J, Born A, Tansella M. Sex differences in the subjective tolerability of antipsychotic drugs. J Clin Psychopharmacol. 2005;25(6):521–6.

    Article  PubMed  Google Scholar 

  8. Grossman LS, Harrow M, Rosen C, Faull R, Strauss GP. Sex differences in schizophrenia and other psychotic disorders: a 20-year longitudinal study of psychosis and recovery. Compr Psychiatry. 2008;49(6):523–9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Seeman MV. Schizophrenia: women bear a disproportionate toll of antipsychotic side effects. J Am Psychiatr Nurses Assoc. 2010;16(1):21–9.

    Article  PubMed  Google Scholar 

  10. Rivera-Garcia MT, McCane AM, Chowdhury TG, Wallin-Miller KG, Moghaddam B. Sex and strain differences in dynamic and static properties of the mesolimbic dopamine system. Neuropsychopharmacology. 2020;45(12):2079–86.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Hoffman GE, Ma Y, Montgomery KS, Bendl J, Jaiswal MK, Kozlenkov A, Peters MA, Dracheva S, Fullard JF, Chess A, et al. Sex differences in the human brain transcriptome of cases with Schizophrenia. Biol Psychiatry. 2022;91(1):92–101.

    Article  PubMed  CAS  Google Scholar 

  12. Shobeiri P, Kalantari A, Teixeira AL, Rezaei N. Shedding light on biological sex differences and microbiota-gut-brain axis: a comprehensive review of its roles in neuropsychiatric disorders. Biol Sex Differ. 2022;13(1):12.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Teshome A, Muche A, Girma B. Prevalence of Dental Caries and Associated factors in East Africa, 2000–2020: systematic review and Meta-analysis. Front Public Health. 2021;9:645091.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Wen YF, Chen MX, Wong HM, Qiang WJ. Trends in the Burden of untreated caries of Permanent Teeth in China, 1993–2017: an age-period-cohort modeling study. Am J Prev Med. 2020;59(6):896–903.

    Article  PubMed  Google Scholar 

  15. Wen PYF, Chen MX, Zhong YJ, Dong QQ, Wong HM. Global Burden and Inequality of Dental Caries, 1990 to 2019. J Dent Res. 2022;101(4):392–9.

    Article  PubMed  CAS  Google Scholar 

  16. Rosa LK, Costa FS, Hauagge CM, Mobile RZ, de Lima AAS, Amaral CDB, Machado RC, Nogueira ARA, Brancher JA, de Araujo MR. Oral health, organic and inorganic saliva composition of men with Schizophrenia: case-control study. J Trace Elem Med Biol. 2021;66:126743.

    Article  PubMed  CAS  Google Scholar 

  17. Gomaa N, Glogauer M, Tenenbaum H, Siddiqi A, Quinonez C. Social-biological interactions in oral disease: a ‘Cells to Society’ View. PLoS ONE. 2016;11(1):e0146218.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Choi J, Price J, Ryder S, Siskind D, Solmi M, Kisely S. Prevalence of dental disorders among people with mental illness: an umbrella review. Aust N Z J Psychiatry. 2022;56(8):949–63.

    Article  PubMed  Google Scholar 

  19. Chapple IL, Bouchard P, Cagetti MG, Campus G, Carra MC, Cocco F, Nibali L, Hujoel P, Laine ML, Lingstrom P, et al. Interaction of lifestyle, behaviour or systemic diseases with dental caries and periodontal diseases: consensus report of group 2 of the joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases. J Clin Periodontol. 2017;44(Suppl 18):39–S51.

    Google Scholar 

  20. Selwitz RH, Ismail AI, Pitts NB. Dental caries. Lancet. 2007;369(9555):51–9.

    Article  PubMed  CAS  Google Scholar 

  21. Sanz M, Beighton D, Curtis MA, Cury JA, Dige I, Dommisch H, Ellwood R, Giacaman RA, Herrera D, Herzberg MC, et al. Role of microbial biofilms in the maintenance of oral health and in the development of dental caries and periodontal diseases. Consensus report of group 1 of the joint EFP/ORCA workshop on the boundaries between caries and periodontal disease. J Clin Periodontol. 2017;44(Suppl 18):5–S11.

    Google Scholar 

  22. Lukacs JR. Gender differences in oral health in South Asia: metadata imply multifactorial biological and cultural causes. Am J Hum Biol. 2011;23(3):398–411.

    Article  PubMed  Google Scholar 

  23. Zhang Z, Wang D, Zhao J, Wang D, Zhang B. Assessment of oral health status and related factors in adolescents aged 12–15 years in the Gansu Province of China: a cross-sectional survey. BMC Oral Health. 2023;23(1):42.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Shao R, Hu T, Zhong YS, Li X, Gao YB, Wang YF, Yin W. Socio-demographic factors, dental status and health-related behaviors associated with geriatric oral health-related quality of life in Southwestern China. Health Qual Life Outcomes. 2018;16(1):98.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Guerreiro E, Botelho J, Machado V, Proenca L, Mendes JJ, Manso AC. Caries experience and risk indicators in a Portuguese Population: a cross-sectional study. Int J Environ Res Public Health 2023, 20(3).

  26. Drachev SN, Brenn T, Trovik TA. Dental caries experience and determinants in young adults of the Northern State Medical University, Arkhangelsk, North-West Russia: a cross-sectional study. BMC Oral Health. 2017;17(1):136.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Lukacs JR, Largaespada LL. Explaining sex differences in dental caries prevalence: saliva, hormones, and life-history etiologies. Am J Hum Biol. 2006;18(4):540–55.

    Article  PubMed  Google Scholar 

  28. Ortiz S, Herrman E, Lyashenko C, Purcell A, Raslan K, Khor B, Snow M, Forsyth A, Choi D, Maier T, et al. Sex-specific differences in the salivary microbiome of caries-active children. J Oral Microbiol. 2019;11(1):1653124.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Yang M, Li Q, Deng C, Yao G, Bai X, Tan X, Zhang X. Prevalence and clinical correlation of Decayed, Missing, and filled Teeth in Elderly Inpatients with Schizophrenia. Front Psychiatry. 2021;12:728971.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Tani H, Uchida H, Suzuki T, Shibuya Y, Shimanuki H, Watanabe K, Den R, Nishimoto M, Hirano J, Takeuchi H, et al. Dental conditions in inpatients with schizophrenia: a large-scale multi-site survey. BMC Oral Health. 2012;12:32.

    Article  PubMed  PubMed Central  Google Scholar 

  31. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. The strengthening the reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9.

    Article  Google Scholar 

  32. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.

    Article  PubMed  CAS  Google Scholar 

  33. Reisberg B, Ferris SH, de Leon MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136–9.

    Article  PubMed  CAS  Google Scholar 

  34. Randolph C, Tierney MC, Mohr E, Chase TN. The repeatable battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol. 1998;20(3):310–9.

    Article  PubMed  CAS  Google Scholar 

  35. Hobdell M, Petersen PE, Clarkson J, Johnson N. Global goals for oral health 2020. Int Dent J. 2003;53(5):285–8.

    Article  PubMed  Google Scholar 

  36. WHO. Oral health surveys: basic methods. 20 Avenue Appia, 1211 Geneva 27. Switzerland: World Health Organization; 2013.

    Google Scholar 

  37. Wong HM, Peng SM, McGrath CPJ. Association of infant growth with emergence of permanent dentition among 12 year-aged southern chinese school children. BMC Oral Health. 2019;19(1):47.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kisely S, Baghaie H, Lalloo R, Siskind D, Johnson NW. A systematic review and meta-analysis of the association between poor oral health and severe mental illness. Psychosom Med. 2015;77(1):83–92.

    Article  PubMed  Google Scholar 

  39. Velasco-Ortega E, Monsalve-Guil L, Ortiz-Garcia I, Jimenez-Guerra A, Lopez-Lopez J, Segura-Egea JJ. Dental caries status of patients with schizophrenia in Seville, Spain: a case-control study. BMC Res Notes. 2017;10(1):50.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Kanasi E, Ayilavarapu S, Jones J. The aging population: demographics and the biology of aging. Periodontol 2000. 2016;72(1):13–8.

    Article  PubMed  Google Scholar 

  41. Maeda H. Aging and senescence of Dental Pulp and hard tissues of the tooth. Front Cell Dev Biol. 2020;8:605996.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Lamster IB, Asadourian L, Del Carmen T, Friedman PK. The aging mouth: differentiating normal aging from disease. Periodontol 2000. 2016;72(1):96–107.

    Article  PubMed  Google Scholar 

  43. Cheung MK, Chan JYK, Wong MCS, Wong PY, Lei P, Cai L, Lan L, Ho WCS, Yeung ACM, Chan PKS, et al. Determinants and interactions of oral bacterial and fungal microbiota in healthy chinese adults. Microbiol Spectr. 2022;10(1):e0241021.

    Article  PubMed  Google Scholar 

  44. Chen L, Zheng T, Yang Y, Chaudhary PP, Teh JPY, Cheon BK, Moses D, Schuster SC, Schlundt J, Li J, et al. Integrative multiomics analysis reveals host-microbe-metabolite interplays associated with the aging process in Singaporeans. Gut Microbes. 2022;14(1):2070392.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Lin D, Hu Q, Yang L, Zeng X, Xiao Y, Wang D, Dai W, Lu H, Fang J, Tang Z, et al. The niche-specialist and age-related oral microbial ecosystem: crosstalk with host immune cells in homeostasis. Microb Genom. 2022;8(6):000811.

    CAS  Google Scholar 

  46. Hernandez-Arriaga A, Baumann A, Witte OW, Frahm C, Bergheim I, Camarinha-Silva A. Changes in oral Microbial Ecology of C57BL/6 mice at different Ages Associated with Sampling Methodology. Microorganisms 2019, 7(9).

  47. Shoemark DK, Allen SJ. The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer’s disease. J Alzheimers Dis. 2015;43(3):725–38.

    Article  PubMed  CAS  Google Scholar 

  48. Aquino-Martinez R, Eckhardt BA, Rowsey JL, Fraser DG, Khosla S, Farr JN, Monroe DG. Senescent cells exacerbate chronic inflammation and contribute to periodontal disease progression in old mice. J Periodontol. 2021;92(10):1483–95.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Chen S, Zhou D, Liu O, Chen H, Wang Y, Zhou Y. Cellular Senescence and Periodontitis: mechanisms and therapeutics. Biology (Basel). 2022;11(10):1419.

    PubMed  CAS  Google Scholar 

  50. Mehtonen IT, Rantala AK, Hugg TT, Jaakkola MS, Jaakkola JJK. Dental caries is associated with lower respiratory tract infections: a population-based cohort study. Respir Med. 2019;158:1–5.

    Article  PubMed  Google Scholar 

  51. Lucchese A. Streptococcus mutans antigen I/II and autoimmunity in cardiovascular diseases. Autoimmun Rev. 2017;16(5):456–60.

    Article  PubMed  CAS  Google Scholar 

  52. Xu YM, Chen HH, Li F, Deng F, Liu XB, Yang HC, Qi LG, Guo JH, Liu TB. Prevalence and correlates of cigarette smoking among chinese schizophrenia inpatients receiving antipsychotic mono-therapy. PLoS ONE. 2014;9(2):e88478.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Olivier D, Lubman DI, Fraser R. Tobacco Smoking within Psychiatric Inpatient Settings: Biopsychosocial Perspective. Aust N Z J Psychiatry. 2007;41(7):572–80.

    Article  PubMed  Google Scholar 

  54. Lucatch AM, Lowe DJE, Clark RC, Kozak K, George TP. Neurobiological determinants of Tobacco Smoking in Schizophrenia. Front Psychiatry. 2018;9:672.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Al-Soufi L, Costas J. Colocalization of association signals at nicotinic acetylcholine receptor genes between schizophrenia and smoking traits. Drug Alcohol Depend. 2021;220:108517.

    Article  PubMed  CAS  Google Scholar 

  56. Ohi K, Kuwata A, Shimada T, Kataoka Y, Yasuyama T, Uehara T, Kawasaki Y. Genome-wide Variants Shared between Smoking Quantity and Schizophrenia on 15q25 are Associated with CHRNA5 expression in the brain. Schizophr Bull. 2019;45(4):813–23.

    Article  PubMed  Google Scholar 

  57. Al-Marzooq F, Al Kawas S, Rahman B, Shearston JA, Saad H, Benzina D, Weitzman M. Supragingival microbiome alternations as a consequence of smoking different tobacco types and its relation to dental caries. Sci Rep. 2022;12(1):2861.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  58. Al-Zyoud W, Hajjo R, Abu-Siniyeh A, Hajjaj S. Salivary microbiome and cigarette smoking: a First of its Kind Investigation in Jordan. Int J Environ Res Public Health 2019, 17(1).

  59. Jia YJ, Liao Y, He YQ, Zheng MQ, Tong XT, Xue WQ, Zhang JB, Yuan LL, Zhang WL, Jia WH. Association between oral microbiota and cigarette smoking in the Chinese Population. Front Cell Infect Microbiol. 2021;11:658203.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Wu J, Li M, Huang R. The effect of smoking on caries-related microorganisms. Tob Induc Dis. 2019;17:32.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  61. Leite FRM, Nascimento GG, Baake S, Pedersen LD, Scheutz F, Lopez R. Impact of Smoking Cessation on Periodontitis: a systematic review and Meta-analysis of prospective longitudinal observational and interventional studies. Nicotine Tob Res. 2019;21(12):1600–8.

    Article  PubMed  Google Scholar 

  62. Krall EA, Dawson-Hughes B, Garvey AJ, Garcia RI. Smoking, smoking cessation, and tooth loss. J Dent Res. 1997;76(10):1653–9.

    Article  PubMed  CAS  Google Scholar 

  63. Delima SL, McBride RK, Preshaw PM, Heasman PA, Kumar PS. Response of subgingival bacteria to smoking cessation. J Clin Microbiol. 2010;48(7):2344–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Ellefsen B, Holm-Pedersen P, Morse DE, Schroll M, Andersen BB, Waldemar G. Caries prevalence in older persons with and without dementia. J Am Geriatr Soc. 2008;56(1):59–67.

    Article  PubMed  Google Scholar 

  65. Abramovitz I, Zini A, Atzmoni M, Kedem R, Zur D, Protter NE, Almoznino G. Cognitive performance and its Associations with Dental Caries: results from the Dental, oral, medical Epidemiological (DOME) Records-Based Nationwide Study. Biology (Basel). 2021;10(3):178.

    PubMed  Google Scholar 

  66. Said-Sadier N, Sayegh B, Farah R, Abbas LA, Dweik R, Tang N, Ojcius DM. Association between Periodontal Disease and cognitive impairment in adults. Int J Environ Res Public Health. 2023;20(6):4707.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  67. Ishida N, Ishihara Y, Ishida K, Tada H, Funaki-Kato Y, Hagiwara M, Ferdous T, Abdullah M, Mitani A, Michikawa M, et al. Periodontitis induced by bacterial infection exacerbates features of Alzheimer’s disease in transgenic mice. NPJ Aging Mech Dis. 2017;3:15.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Lu J, Zhang S, Huang Y, Qian J, Tan B, Qian X, Zhuang J, Zou X, Li Y, Yan F. Periodontitis-related salivary microbiota aggravates Alzheimer’s disease via gut-brain axis crosstalk. Gut Microbes. 2022;14(1):2126272.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, Nguyen M, Haditsch U, Raha D, Griffin C, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5(1):eaau3333.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Noble JM, Borrell LN, Papapanou PN, Elkind MS, Scarmeas N, Wright CB. Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-III. J Neurol Neurosurg Psychiatry. 2009;80(11):1206–11.

    Article  PubMed  CAS  Google Scholar 

  71. Poole S, Singhrao SK, Kesavalu L, Curtis MA, Crean S. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue. J Alzheimers Dis. 2013;36(4):665–77.

    Article  PubMed  CAS  Google Scholar 

  72. Arnaiz A, Zumarraga M, Diez-Altuna I, Uriarte JJ, Moro J, Perez-Ansorena MA. Oral health and the symptoms of schizophrenia. Psychiatry Res. 2011;188(1):24–8.

    Article  PubMed  Google Scholar 

  73. Singh A, Mittal P, Goel P, Purohit BM, Thukral R. Severity of illness and extra pyramidal symptoms as predictors for oral diseases among patients with schizophrenia. Acta Odontol Scand. 2017;75(3):220–6.

    Article  PubMed  Google Scholar 

  74. Holbrook SYL, Garzan A, Dennis EK, Shrestha SK, Garneau-Tsodikova S. Repurposing antipsychotic drugs into antifungal agents: synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections. Eur J Med Chem. 2017;139:12–21.

    Article  PubMed  CAS  Google Scholar 

  75. Flowers SA, Evans SJ, Ward KM, McInnis MG, Ellingrod VL. Interaction between atypical antipsychotics and the gut microbiome in a bipolar Disease Cohort. Pharmacotherapy. 2017;37(3):261–7.

    Article  PubMed  CAS  Google Scholar 

  76. Yuan X, Zhang P, Wang Y, Liu Y, Li X, Kumar BU, Hei G, Lv L, Huang XF, Fan X, et al. Changes in metabolism and microbiota after 24-week risperidone treatment in drug naive, normal weight patients with first episode schizophrenia. Schizophr Res. 2018;201:299–306.

    Article  PubMed  Google Scholar 

  77. Cleaver LM, Carda-Dieguez M, Moazzez R, Carpenter GH. Novel bacterial proteolytic and metabolic activity associated with dental erosion-induced oral dysbiosis. Microbiome. 2023;11(1):69.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  78. Chen J, Yang P, Zhang Q, Chen R, Wang P, Liu B, Sun W, Jian X, Xiang S, Zhou J, et al. Genetic risk of clozapine-induced leukopenia and neutropenia: a genome-wide association study. Transl Psychiatry. 2021;11(1):343.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  79. Kaar SJ, Natesan S, McCutcheon R, Howes OD. Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology. 2020;172:107704.

    Article  PubMed  CAS  Google Scholar 

  80. Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry. 2018;17(3):341–56.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Ngo DYJ, Thomson WM, Subramaniam M, Abdin E, Ang KY. The oral health of long-term psychiatric inpatients in Singapore. Psychiatry Res. 2018;266:206–11.

    Article  PubMed  Google Scholar 

  82. Soares MA, Costa ALA, Silva NLC, Martins AF, Matias DO, Araujo OMO, Lopes RT, Takiya CM, Miranda ALP, Miranda-Alves L, et al. Atypical antipsychotics olanzapine and clozapine increase bone loss in female rats with experimental periodontitis. J Periodontal Res. 2023;58(2):283–95.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

None.

Funding

This research was funded by National Natural Science Foundation of China (62073058), Chengdu Science and Technology Bureau (2022-YF05-01867-SN), Chengdu Municipal Health Commission (2021057, 2022662), the Science and Technology Plan Project of Guangdong Province (2019B030316001), Guangzhou municipal key discipline in medicine (2021–2023) and Open Project Program of State Key Laboratory of Virtual Reality Technology and Systems, Beihang University (No.VRLAB2022 B02), and Shanghai Key Laboratory of Psychotic Disorders Open Grant (21-K03).

Author information

Authors and Affiliations

  1. Department of Psychiatry, The Fourth People’s Hospital of Chengdu, No.8 Huli-West 1st-Alley, Jinniu District, Chengdu, 610036, China

    Mi Yang, Di Kong, Yan Yang & Wei Chen

  2. MOE Key Lab for Neuroinformation, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Qingshuihe Campus: No.2006, Xiyuan Ave, West Hi-Tech Zone, Chengdu, 611731, China

    Mi Yang

  3. School of Life Science and Technology, University of Electronic Science and Technology of China, Qingshuihe Campus: No.2006, Xiyuan Ave, West Hi-Tech Zone, Chengdu, 611731, China

    Mi Yang & Liju Liu

  4. Department of Psychiatry, Qingdao mental health center, No. 299, Nanjing Road, Qingdao, 266034, China

    Jingjing Xu & Xiaoqin Chen

  5. Department of Nutritional and Metabolic Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University, 36 Mingxin Road, Liwan District, Guangzhou, 510370, China

    Zezhi Li

  6. Department of Psychiatry, Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, 36 Mingxin Road, Liwan District, Guangzhou, 510370, China

    Zezhi Li

  7. Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, Ministry of Education of China, Guangzhou Medical University, 36 Mingxin Road, Liwan District, Guangzhou, 510370, China

    Zezhi Li

  8. CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, 16 Lincui Road, Chaoyang District, Beijing, 100101, China

    Xiangyang Zhang

Authors
  1. Mi Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jingjing Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaoqin Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Liju Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Di Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wei Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zezhi Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xiangyang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization: Mi Yang, Zezhi Li, Xiangyang Zhang; Methodology: Mi Yang, Zezhi Li; Formal analysis and investigation: Mi Yang, Jingjing Xu, Xiaoqin Chen, Liju Liu; Writing - original draft preparation: Mi Yang, Liju Liu; Writing - review and editing: All authors commented on previous versions of the manuscript; Funding acquisition: Mi Yang, Zezhi Li; Supervision: Zezhi Li, Xiangyang Zhang. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Zezhi Li or Xiangyang Zhang.

Ethics declarations

Ethics approval and consent to participate

The Beijing Huilongguan Hospital Ethics Committee approved the study, and all patients or their legal guardians provided written informed consent. The protocol involving human participants and human data has been performed in accordance with the Declaration of Helsinki. This reporting was performed per the Strengthening the Reporting of Observational studies in Epidemiology (STROBE) guidance.

Consent for publication

Not Applicable.

Conflict of interest

The authors declare that they have no conflict of interest.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

12888_2023_5256_MOESM1_ESM.docx

Supplementary Material 1: Supplementary Table 1. The correlation between risk factors and caries in male and female patients with schizophrenia.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, M., Xu, J., Chen, X. et al. Sex-based influential factors for dental caries in patients with schizophrenia. BMC Psychiatry 23, 735 (2023). https://doi.org/10.1186/s12888-023-05256-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12888-023-05256-z

Keywords

BMC Psychiatry

ISSN: 1471-244X

Contact us